Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Mukdahan International Hospital PCL EV-to-EBITDA?
Mukdahan International Hospital PCLBKK:HANN 17 EV-to-EBITDA is 8.43 as of Aug. 20, 2026, which is 4% below its 10-year median of 8.77. GuruFocus rates BKK:HANN with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Mukdahan International Hospital PCL ranks better than 63.55% on this metric.
BKK:HANN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.45 Med: 8.77 Max: 19.75
Current: 8.42
During the past 3 years, the highest EV-to-EBITDA of Mukdahan International Hospital PCL was 19.75. The lowest was 6.45. And the median was 8.77.
BKK:HANN's EV-to-EBITDA is ranked better than 63.55% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs BKK:HANN: 8.42
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Mukdahan International Hospital PCL (BKK:HANN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mukdahan International Hospital PCL's PE Ratio (TTM) for today is calculated as:
Mukdahan International Hospital PCL's share price for today is ฿0.83.
Mukdahan International Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukdahan International Hospital PCL EV-to-EBITDA Chart
Mukdahan International Hospital PCL Annual Data
Trend
Dec23
Dec24
Dec25
EV-to-EBITDA
0.00
0.00
8.08
Mukdahan International Hospital PCL Quarterly Data
BKK:HANN vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Mukdahan International Hospital PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mukdahan International Hospital PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Mukdahan International Hospital PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Mukdahan International Hospital PCL's EV-to-EBITDA falls into.
Mukdahan International Hospital PCL's current Enterprise Value is ฿407.1 Mil.
Mukdahan International Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿48.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mukdahan International Hospital PCL (BKK:HANN) has a EV-to-EBITDA of 8.43 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mukdahan International Hospital PCL. This is near median its historical median of 8.77. Over the past decade, Mukdahan International Hospital PCL's EV-to-EBITDA has ranged from 6.45 to 19.75. According to the industry distribution chart, Mukdahan International Hospital PCL ranks #187 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 36.5%.
Is Mukdahan International Hospital PCL's EV-to-EBITDA too high?
Mukdahan International Hospital PCL's current EV-to-EBITDA of 8.43 is near median its 10-year median of 8.77. Over the past 10 years, this metric has ranged from a low of 6.45 to a high of 19.75. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. Mukdahan International Hospital PCL's value of 8.43 is 21.7% below this industry median. Based on the distribution chart, Mukdahan International Hospital PCL ranks #187 out of 513 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mukdahan International Hospital PCL has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Mukdahan International Hospital PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Mukdahan International Hospital PCL ranks #187 out of 513 companies for EV-to-EBITDA. This puts Mukdahan International Hospital PCL in the upper half of its industry. The industry median EV-to-EBITDA is 10.76. Mukdahan International Hospital PCL's value of 8.43 is 21.7% below this benchmark. Historically, Mukdahan International Hospital PCL's own EV-to-EBITDA has ranged from 6.45 to 19.75 over the past decade. While the company's 10-year median is 8.77 vs. the industry median of 10.76, Mukdahan International Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mukdahan International Hospital PCL's current EV-to-EBITDA of 8.43 is 21.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Mukdahan International Hospital PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mukdahan International Hospital PCL's current EV-to-EBITDA is 8.43, which is near median its own 10-year median of 8.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mukdahan International Hospital PCL stock overvalued right now?
Mukdahan International Hospital PCL (BKK:HANN) has a current EV-to-EBITDA of 8.43. The current EV-to-EBITDA is 8.43, which is near median its 10-year median of 8.77 and 21.7% below the Healthcare Providers & Services industry median of 10.76. Mukdahan International Hospital PCL's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Mukdahan International Hospital PCL (BKK:HANN), the current EV-to-EBITDA is 8.43 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mukdahan International Hospital PCL is engaged in providing comprehensive treatment services for a wide range of specialized diseases. There are three private hospitals under the company group, namely: Mukdahan International Hospital, Dr. Han Hospital, and Ruam Phaet Yasothon Hospital, which provide comprehensive services over 16 medical centers and clinics.
17GF Score
Get the complete analysis for BKK:HANN
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:HANN has been successfully added to your 
